Related Experiment Video
Updated: Mar 14, 2026

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Pathways to chronic benzodiazepine use: a qualitative study of user and professional perspectives
M Teresa Peñarrubia-Maria1,2,3,4,5, Mª Carmen Olmos-Palenzuela6,7,8,9, Montserrat Gil-Girbau8,9,10
1Centro de Atención Primaria Bartomeu Fabrés Anglada, Gerencia Territorial Metropolitana Sud, Institut Català de la Salut, c/Riera de les Parets, 7, Gavà, Barcelona, 08850, España. mtpenarrubia.apms.ics@gencat.cat.
No abstract available in PubMed .
More Related Videos
05:12Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Pharmacodynamics in Geriatric Patients: Effects of Age